Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones

Dopamine-containing neurones of the ventral tegmental area express neurotensin receptors which are involved in regulating cell firing and dopamine release. Although indirect evidence suggests that some neurotensin receptors may be localised on the nerve terminals of dopaminergic neurones in the striatum and thus locally regulate dopamine release, a clear demonstration of such a mechanism is lacking and a number of indirect sites of action are possible. We have taken advantage of a simplified preparation in which cultured rat ventral tegmental area dopaminergic neurones establish nerve terminals that co-release glutamate to determine whether neurotensin can act at presynaptic sites. We recorded glutamate-mediated synaptic currents that were generated by dopaminergic nerve terminals as an index of presynaptic function. The neurotensin receptor agonist NT(8-13) caused an inward current and an enhancement of the firing rate of dopaminergic neurones together with an increase in the frequency of spontaneous glutamate receptor-mediated excitatory postsynaptic currents (EPSCs). Incompatible with a direct excitatory action on nerve terminals, NT(8-13) failed to change the amplitude of individual action potential-evoked EPSCs or the frequency of miniature EPSCs recorded in the presence of tetrodotoxin. However, NT(8-13) reduced the ability of terminal D2 dopamine receptors to inhibit action potential-evoked EPSCs in isolated dopaminergic neurones. Taken together, our results suggest that in addition to its well-known somatodendritic excitatory effect leading to an increase in firing rate, neurotensin also acts on nerve terminals. The main effect of neurotensin on nerve terminals is not to produce a direct excitation, but rather to decrease the effectiveness of D2 receptor-mediated presynaptic inhibition.

[1]  P. Kalivas,et al.  Dopamine regulation of extracellular glutamate in the nucleus accumbens , 1997, Brain Research.

[2]  S. Haber,et al.  Dopamine Neurons Make Glutamatergic Synapses In Vitro , 1998, The Journal of Neuroscience.

[3]  S. Ceccatelli,et al.  A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin , 1988, Brain Research.

[4]  N. Mercuri,et al.  Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  R. Leyris,et al.  Neurochemical and behavioural effects of neurotensin vs [D-Tyr11]neurotensin on mesolimbic dopaminergic function , 1995, Neuropeptides.

[6]  L. Cubeddu,et al.  Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. , 1990, The Journal of pharmacology and experimental therapeutics.

[7]  U. Ungerstedt,et al.  Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Sulzer,et al.  Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  E. Audinat,et al.  Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro , 2004, Experimental Brain Research.

[10]  B. Bunney,et al.  Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity , 1991, Brain Research.

[11]  P. Kalivas,et al.  Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  R. North,et al.  Neurotensin excitation of rat ventral tegmental neurones. , 1994, The Journal of physiology.

[13]  K. Fuxe,et al.  Neurotensin increases endogenous glutamate release in rat cortical slices. , 2000, Life sciences.

[14]  U. Ungerstedt,et al.  Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum , 1989, Brain Research.

[15]  S. Kombian,et al.  Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro , 1997, Neuroscience.

[16]  J. Desce,et al.  Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes , 1994, Neurochemistry International.

[17]  C. Kruse,et al.  Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area , 1999, Neuroscience.

[18]  Tony Wu,et al.  Neurotensin increases the cationic conductance of rat substantia nigra dopaminergic neurons through the inositol 1,4,5-trisphosphate-calcium pathway , 1995, Brain Research.

[19]  R. Farkas,et al.  Properties of a slow nonselective cation conductance modulated by neurotensin and other neurotransmitters in midbrain dopaminergic neurons. , 1996, Journal of neurophysiology.

[20]  W. Rostène,et al.  Use of Nonpeptide Antagonists to Explore the Physiological Roles of Neurotensin , 1997, Annals of the New York Academy of Sciences.

[21]  Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments. , 1990, The Journal of pharmacology and experimental therapeutics.

[22]  Michel Heaulme,et al.  Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KC1 versus electrical depolarization , 1997, Neuropharmacology.

[23]  L. Trudeau,et al.  GDNF enhances the synaptic efficacy of dopaminergic neurons in culture , 2000, The European journal of neuroscience.

[24]  R. Pinnock Neurotensin depolarizes substantia nigra dopamine neurones , 1985, Brain Research.

[25]  U. Ungerstedt,et al.  Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. , 1995, Synapse.

[26]  P. Soubrié,et al.  Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: A combined in vivo electrochemical and electrophysiological study , 1998, Neuroscience.

[27]  K. Fuxe,et al.  Differential Effects of lntrastriatal Neurotensin(1–13) and Neurotensin(8–13) on Striatal Dopamine and Pallidal GABA Release. A Dual‐probe Microdialysis Study in the Awake Rat , 1997, The European journal of neuroscience.

[28]  F. Michel,et al.  Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture , 2000, Neuropharmacology.

[29]  J. Crawley,et al.  Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens , 1990, Brain Research.

[30]  P. Soubrié,et al.  Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr11]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens , 2000, Neuroscience.

[31]  G. Aghajanian,et al.  Neurotensin Excitation of Serotonergic Neurons in the Dorsal Raphe Nucleus of the Rat In Vitro , 1996, The European journal of neuroscience.

[32]  S. St.-Pierre,et al.  Relationships between structure and duration of neurotensin's central action: Emergence of long acting analogs , 1984, Neuropeptides.

[33]  A. Beaudet,et al.  Differential Binding Profile and Internalization Process of Neurotensin via Neuronal and Glial Receptors , 1997, The Journal of Neuroscience.

[34]  P. Soubrié,et al.  Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. , 1997, The Journal of pharmacology and experimental therapeutics.

[35]  C. Nemeroff,et al.  Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin , 1976, Nature.

[36]  M. Sheehan,et al.  Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[37]  S. Vicini,et al.  A pyridazinyl derivative of gamma-aminobutyric acid (GABA), SR 95531, is a potent antagonist of Cl− channel opening regulated by GABAA receptors , 1987, Neuropharmacology.

[38]  P. Soubrié,et al.  Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons , 1998, Neuroscience.

[39]  R. Romo,et al.  In vivo presynaptic control of dopamine release in the cat caudate nucleus—III. Further evidence for the implication of corticostriatal glutamatergic neurons , 1986, Neuroscience.

[40]  J. Leysen,et al.  Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain. , 1989, Journal of chemical neuroanatomy.

[41]  P. Rompré,et al.  Mesencephalic microinjections of neurotensin-(1–13) and its C-terminal fragment, neurotensin-(8–13), potentiate brain stimulation reward , 1993, Brain Research.

[42]  R. Quirion,et al.  Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals , 1985, Brain Research.

[43]  J. Desce,et al.  Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum. , 1991, The Journal of pharmacology and experimental therapeutics.

[44]  A. Dresse,et al.  Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro , 1989, Neuropharmacology.

[45]  K. Fuxe,et al.  The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate–GABA Interaction via the Pallidal–Subthalamic Nucleus Loop , 1998, The Journal of Neuroscience.

[46]  L. Trudeau Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors , 2000, Neuroscience.

[47]  P. Rompré,et al.  Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization , 2000, Neuropharmacology.

[48]  R. Carraway,et al.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. , 1973, The Journal of biological chemistry.

[49]  P. Rompré,et al.  Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13). , 1992, European journal of pharmacology.

[50]  R. Quirion Interactions between neurotensin and dopamine in the brain: An overview , 1983, Peptides.

[51]  K. Fuxe,et al.  Neurotensin Decreases the Affinity of Dopamine D2 Agonist Binding by a G Protein‐Independent Mechanism , 1991, Journal of neurochemistry.

[52]  A. Beaudet,et al.  Neurotensin promotes oscillatory bursting behavior and is internalized in basal forebrain cholinergic neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.